1. Repository of OAI
Ελληνικά   English  

Browsing by Author Hatzimichael, E.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 10 to 20 of 20 < previous 
TitleAuthor(s)Issue date???itemlist.???
Polo-like kinase 2 (SNK/PLK2) is a novel epigenetically regulated gene in acute myeloid leukemia and myelodysplastic syndromes: genetic and epigenetic interactionsBenetatos, L.; Dasoula, A.; Hatzimichael, E.; Syed, N.; Voukelatou, M.; Dranitsaris, G.; Bourantas, K. L.; Crook, T.24-Nov-2015-
The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasiaHatzimichael, E.; Dasoula, A.; Shah, R.; Syed, N.; Papoudou-Bai, A.; Coley, H. M.; Dranitsaris, G.; Bourantas, K. L.; Stebbing, J.; Crook, T.24-Nov-2015-
Promoter hypermethylation of the MEG3 (DLK1/MEG3) imprinted gene in multiple myelomaBenetatos, L.; Dasoula, A.; Hatzimichael, E.; Georgiou, I.; Syrrou, M.; Bourantas, K. L.24-Nov-2015-
Revisiting bleomycin from pathophysiology to safe clinical useFroudarakis, M.; Hatzimichael, E.; Kyriazopoulou, L.; Lagos, K.; Pappas, P.; Tzakos, A. G.; Karavasilis, V.; Daliani, D.; Papandreou, C.; Briasoulis, E.24-Nov-2015-
Serum adipocytokine and vascular inflammation marker levels in Beta-thalassaemia major patientsChaliasos, N.; Challa, A.; Hatzimichael, E.; Koutsouka, F.; Bourantas, D.; Vlahos, A. P.; Siamopoulou, A.; Bourantas, K. L.; Makis, A.24-Nov-2015-
Spontaneous splenic haematoma in a multiple myeloma patient receiving pegfilgrastim supportHatzimichael, E.; Benetatos, L.; Stebbing, J.; Kapsali, E.; Panayiotopoulou, S.; Bourantas, K. L.24-Nov-2015-
Targeting Oncogenic Protein-Protein Interactions by Diversity Oriented Synthesis and Combinatorial Chemistry ApproachesFokas, D.; Briasoulis, E.; Johannes, C.; Moussis, V.; Hatzimichael, E.; Tzakos, A. G.24-Nov-2015-
Targeting Oncogenic Protein-Protein Interactions by Diversity Oriented Synthesis and Combinatorial Chemistry ApproachesTzakos, A. G.; Fokas, D.; Johannes, C.; Moussis, V.; Hatzimichael, E.; Briasoulis, E.24-Nov-2015-
Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion moleculesChaidos, A.; Makis, A.; Hatzimichael, E.; Tsiara, S.; Gouva, M.; Tzouvara, E.; Bourantas, K. L.24-Nov-2015-
Treatment of plasma cell leukemia with vincristine, liposomal doxorubicin and dexamethasoneChristou, L.; Hatzimichael, E.; Chaidos, A.; Tsiara, S.; Bourantas, K. L.24-Nov-2015-
Von Hippel-Lindau methylation status in patients with multiple myeloma: a potential predictive factor for the development of bone diseaseHatzimichael, E.; Dranitsaris, G.; Dasoula, A.; Benetatos, L.; Stebbing, J.; Crook, T.; Bourantas, K. L.24-Nov-2015-
Showing results 10 to 20 of 20 < previous